EQ
Equillium, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.21
−0.45%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-32.1%
Return on equity
-30.7%
Return on assets
-34.1%
Return on invested capital
0.00x
Asset turnover
-$20.0M
Cash from operations
$0.90
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026